These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6188035

  • 1. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.
    Olianas MC, Onali P, Neff NH, Costa E.
    Mol Pharmacol; 1983 Mar; 23(2):393-8. PubMed ID: 6188035
    [Abstract] [Full Text] [Related]

  • 2. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P, Olianas MC, Gessa GL.
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [Abstract] [Full Text] [Related]

  • 3. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 4. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart.
    Olianas MC, Onali P.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):680-6. PubMed ID: 1658307
    [Abstract] [Full Text] [Related]

  • 5. Muscarinic receptor regulation of NG108-15 adenylate cyclase: requirement for Na+ and GTP.
    Lichtshtein D, Boone G, Blume A.
    J Cyclic Nucleotide Res; 1979 Oct; 5(5):367-75. PubMed ID: 521545
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE, Neff NH, Hadjiconstantinou M.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [Abstract] [Full Text] [Related]

  • 7. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
    Onali P, Olianas MC.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
    [Abstract] [Full Text] [Related]

  • 8. Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy.
    Keen M, Nahorski SR.
    Mol Pharmacol; 1988 Dec; 34(6):769-78. PubMed ID: 3200249
    [Abstract] [Full Text] [Related]

  • 9. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes.
    Waelbroeck M, Robberecht P, Chatelain P, Christophe J.
    J Cyclic Nucleotide Res; 1981 Dec; 7(3):173-85. PubMed ID: 7287969
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the regulatory properties of striatal and cortical adenylate cyclase.
    Dokas LA, Ting SM.
    Neurobiol Aging; 1993 Dec; 14(1):65-72. PubMed ID: 8450935
    [Abstract] [Full Text] [Related]

  • 11. (R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptors.
    Zorn SH, Duman RS, Giachetti A, Micheletti R, Giraldo E, Krogsgaard-Larsen P, Enna SJ.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):173-8. PubMed ID: 2886636
    [Abstract] [Full Text] [Related]

  • 12. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM, Bier-Laning CM, Halford MK, Ahlijanian MK, Zahniser NR.
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [Abstract] [Full Text] [Related]

  • 13. Involvement of a high-affinity GTPase in the inhibitory coupling of striatal muscarinic receptors to adenylate cyclase.
    Onali P, Olianas MC, Schwartz JP, Costa E.
    Mol Pharmacol; 1983 Nov; 24(3):380-6. PubMed ID: 6138702
    [Abstract] [Full Text] [Related]

  • 14. Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations.
    Ehlert FJ, Rathbun BE.
    Mol Pharmacol; 1990 Jul; 38(1):148-58. PubMed ID: 2370853
    [Abstract] [Full Text] [Related]

  • 15. Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum.
    Westlind-Danielsson A, Andell S, Abens J, Bartfai T.
    Acta Physiol Scand; 1988 Mar; 132(3):425-30. PubMed ID: 2852438
    [Abstract] [Full Text] [Related]

  • 16. Muscarinic cholinergic receptor-mediated activation of phosphodiesterase.
    Meeker RB, Harden TK.
    Mol Pharmacol; 1982 Sep; 22(2):310-9. PubMed ID: 6183568
    [No Abstract] [Full Text] [Related]

  • 17. In rat hippocampus, somatostatin 14 and muscarinic receptor ligands modulate an adenylate cyclase belonging to a common domain of the receptor.
    Eva C, Costa E.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):888-94. PubMed ID: 2888875
    [Abstract] [Full Text] [Related]

  • 18. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. I. Analysis of agonist sensitivity.
    Olianas MC, Onali P.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):673-9. PubMed ID: 1941616
    [Abstract] [Full Text] [Related]

  • 19. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
    Huff RA, Corcoran JJ, Anderson JK, Abou-Donia MB.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):329-35. PubMed ID: 7513360
    [Abstract] [Full Text] [Related]

  • 20. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.